Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Feb;16(2):141-8.
doi: 10.1111/jch.12258.

Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches

Affiliations
Case Reports

Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches

Alexandros Briasoulis et al. J Clin Hypertens (Greenwich). 2014 Feb.

Abstract

Orthostatic hypotension (OH) is a relatively common heterogeneous and multifactorial disorder often caused by autonomic dysfunction. This condition has a deleterious impact on quality of life and contributes to higher mortality rates. Supine hypertension is very common in patients with autonomic failure, limits the use of pressor agents, and can result in end-organ damage. Current recommendations on the optimal management of these patients are based on expert opinion and poor-quality small cross-sectional studies including patients with primary autonomic failure and severe orthostatic hypotension. The authors present their treatment approach in 12 patients with disabling orthostatic hypotension and supine hypertension not related to primary autonomic failure, presenting to a referral center over a 4-year period. The first step is to educate the patient about the pathophysiology and course of their disorder. Nonpharmacologic therapies and maneuvers are usually effective in relieving symptoms and preventing syncope. If needed, pharmacologic options such as fludrocortisones and midodrine are also available in patients with severe symptoms. Supine hypertension represents a challenge in the treatment of this condition. Therefore, elevation of the bed of the head and dosing of short-acting antihypertensive agents at bedtime is often indicated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Treatment approach to patients with orthostatic hypotension with supine hypertension. The goal is to reduce delta blood pressure (BP) between supine and standing to <30 to 40 mm Hg and eliminate or reduce symptoms upon standing. Step 1: If symptomatic upon sitting or standing with significant BP drop >30 mm Hg (a) use moderate thigh‐high support stocking (about 30–35 mm Hg) or (b) use a teaspoon of salt with an intermediate β‐blocker, ie, atenolol or longer‐acting central α‐agonist, ie, such as guanfacine at bedtime if BP >150 mm Hg supine and heart rate >72 beats per minute. Consider nicardipine 20 mg if heart rate low. Step 2: If the above fail, add low‐dose fluoridated steroids daily. Step 3: Add midodrine 5 mg in the morning and perhaps another dose in early afternoon, but avoid titration too quickly as it can cause hypertension. SBP indicates systolic blood pressure; DBP, diastolic blood pressure.
Figure 2
Figure 2
Mean standing home blood pressure.
Figure 3
Figure 3
Mean supine home blood pressure.

Similar articles

Cited by

References

    1. Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med. 2007;120:841–847. - PubMed
    1. Shapiro MH, Ruiz‐Ramon P, Fainman C, Ziegler MG. Light‐headedness and defective cardiovascular reflexes after neck radiotherapy. Blood Press Monit. 1996;1:81–85. - PubMed
    1. Smit AA, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol. 1999;519(Pt 1):1–10. - PMC - PubMed
    1. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. 2011;161:46–48. - PubMed
    1. Shannon J, Jordan J, Costa F, et al. The hypertension of autonomic failure and its treatment. Hypertension. 1997;30:1062–1067. - PubMed

Publication types

MeSH terms